While many eye supplements focus on the macula and retina, a growing segment of the Eye Health Supplements Market is dedicated to addressing chronic conditions such as dry eye syndrome, which affects millions globally and is often associated with inflammation and tear film instability, and the increasing incidence of dry eye, exacerbated by environmental factors and extended screen time, is creating a large, distinct opportunity within the broader Eye Health Supplements Market. This area requires specific nutritional interventions focused on anti-inflammatory effects.

Omega-3 fatty acids, particularly those derived from marine sources like fish oil (EPA and DHA), are the primary ingredients in this segment. They are believed to reduce systemic inflammation and improve the lipid layer of the tear film, crucial for preventing tear evaporation. High-concentration, pharmaceutical-grade Omega-3 products are often recommended over standard fish oil for clinical effect in dry eye. Other emerging ingredients for ocular surface health include flaxseed oil (a plant-based Omega-3 source), sea buckthorn oil, and certain Gamma-Linolenic Acid (GLA) sources, demonstrating the market's continuous search for new, effective, and well-tolerated formulations.

Related Reports